This topic contains a solution. Click here to go to the answer

Author Question: Which of the following variables determine the level of support achieved with adaptive support ... (Read 74 times)

Chloeellawright

  • Hero Member
  • *****
  • Posts: 588
Which of the following variables determine the level of support achieved with adaptive support ventilation?
 
  1. Patient effort
  2. Elastance
  3. Resistance of the endotracheal tube
  a. 1 and 3 only
  b. 2 only
  c. 1 only
  d. 1, 2, and 3

Question 2

What factor primarily determines the effect of positive-pressure ventilation (PPV) on the cardiac output?
 
  a. Peak airway pressure
  b. Mean pleural pressure
  c. CO2
  d. Expiratory time



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

AISCAMPING

  • Sr. Member
  • ****
  • Posts: 347
Answer to Question 1

ANS: A
Automatic tube compensation is similar to the flow assist of proportional assist ventilation but only considers the resistance of the endotracheal tube.

Answer to Question 2

ANS: B
More specifically, the decrease in left ventricular output corresponded to the increase in pleural pressure that occurred with PPV.




Chloeellawright

  • Member
  • Posts: 588
Reply 2 on: Jul 16, 2018
YES! Correct, THANKS for helping me on my review


dantucker

  • Member
  • Posts: 346
Reply 3 on: Yesterday
:D TYSM

 

Did you know?

Cucumber slices relieve headaches by tightening blood vessels, reducing blood flow to the area, and relieving pressure.

Did you know?

The term bacteria was devised in the 19th century by German biologist Ferdinand Cohn. He based it on the Greek word "bakterion" meaning a small rod or staff. Cohn is considered to be the father of modern bacteriology.

Did you know?

ACTH levels are normally highest in the early morning (between 6 and 8 A.M.) and lowest in the evening (between 6 and 11 P.M.). Therefore, a doctor who suspects abnormal levels looks for low ACTH in the morning and high ACTH in the evening.

Did you know?

Bisphosphonates were first developed in the nineteenth century. They were first investigated for use in disorders of bone metabolism in the 1960s. They are now used clinically for the treatment of osteoporosis, Paget's disease, bone metastasis, multiple myeloma, and other conditions that feature bone fragility.

Did you know?

The first monoclonal antibodies were made exclusively from mouse cells. Some are now fully human, which means they are likely to be safer and may be more effective than older monoclonal antibodies.

For a complete list of videos, visit our video library